Mark Litzow

Mark Litzow

UNVERIFIED PROFILE

Are you Mark Litzow?   Register this Author

Register author
Mark Litzow

Mark Litzow

Publications by authors named "Mark Litzow"

Are you Mark Litzow?   Register this Author

100Publications

2837Reads

49Profile Views

Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia.

Nat Commun 2019 Nov 7;10(1):5051. Epub 2019 Nov 7.

Department of Hematology-Oncology, International Cancer Center, Shenzhen University General Hospital, Shenzhen University Health Science Center, 1098 Xueyuan Ave, 518060, Shenzhen, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-12960-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838331PMC
November 2019

Two-dimensional speckle-tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemia.

Echocardiography 2019 Nov 8;36(11):2033-2040. Epub 2019 Nov 8.

Division of Cardiovascular Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/echo.14518DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874906PMC
November 2019

PD-1/PD-L1 expression in extramedullary lesions of acute myeloid leukemia.

Leuk Lymphoma 2019 Oct 12:1-4. Epub 2019 Oct 12.

Division of Hematology, Department of Internal Medicine, Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1675880DOI Listing
October 2019

Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U): single center experience.

Leuk Lymphoma 2019 Oct 7;60(10):2483-2487. Epub 2019 Mar 7.

Division of Hematology, Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1581930DOI Listing
October 2019

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.

Haematologica 2019 09 26. Epub 2019 Sep 26.

Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.220756DOI Listing
September 2019

Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection.

Biol Blood Marrow Transplant 2019 Aug 26;25(8):e260-e267. Epub 2019 Mar 26.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.03.021DOI Listing
August 2019

Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.

N Engl J Med 2019 08;381(5):432-443

From Stanford University, Stanford (T.D.S., S.E.C.), the University of California, Irvine, Medical Center, Orange (S.O.), and Kaiser Permanente National Cancer Institute Community Oncology Research Program (NCORP)-Permanente Medical Group, Oakland (C.C.Z.) - all in California; Dana-Farber Cancer Institute, Boston (X.V.W., R.M.S.); Mayo Clinic, Rochester (N.E.K., C.A.H., J.F.L., M.L.), and Minnesota Oncology, Burnsville (A.K.S.) - both in Minnesota; Northwell Health Cancer Institute, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Lake Success (J.B.), and University of Rochester, Rochester (P.M.B.) - both in New York; Mayo Clinic, Phoenix, AZ (D.F.J., E.B.); Washington University School of Medicine, St. Louis (A.F.C.); Memorial Sloan Kettering Cancer Center, New York (A.R.M., M.T.); Aurora Cancer Care, West Allis, WI (M.P.M.); National Cancer Institute, Bethesda, MD (R.F.L.); and the University of Alabama, Tuscaloosa (H.E.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1817073DOI Listing
August 2019

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

Haematologica 2019 Apr 31;104(4):844-854. Epub 2018 Oct 31.

Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.

View Article

Download full-text PDF

Source
http://www.haematologica.org/lookup/doi/10.3324/haematol.201
Publisher Site
http://dx.doi.org/10.3324/haematol.2018.200121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442962PMC
April 2019

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Biol Blood Marrow Transplant 2019 04 10;25(4):699-711. Epub 2018 Nov 10.

Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota; National Marrow Donor Program/Be the Match, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.11.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453753PMC
April 2019

Allogeneic transplantation for patients with Philadelphia chromosome positive acute lymphoblastic leukemia: Is it imperative in the tyrosine kinase inhibitor era?

Authors:
Mark R Litzow

Best Pract Res Clin Haematol 2018 12 20;31(4):357-360. Epub 2018 Sep 20.

Division of Hematology and Blood and Marrow Transplant, Mayo Clinic, 200 1st Street South West, Rochester, MN 55905, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2018.09.004DOI Listing
December 2018

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.

N Engl J Med 2018 12 1;379(26):2517-2528. Epub 2018 Dec 1.

From Ohio State University Comprehensive Cancer Center, Columbus (J.A.W., A.S.R., N.A.H., W.Z., K.A.R., G.L., J.S.B., H.G.O., J.C.B.); the Alliance Statistics and Data Center (A.S.R., A.M.B., B.M.-E., B.F., S.J.M.), Mayo Clinic (W.D., S.A.P., M.L.), Rochester, MN; Washington University School of Medicine, St. Louis (N.L.B.); Duke Cancer Institute, Duke University Medical Center, Durham (D.M.B., H.E.), and First Health of the Carolinas Cancer Center, Pinehurst (C.K.) - both in North Carolina; the University of Rochester Medical Center, Rochester, NY (P.M.B.); Stanford University School of Medicine, Stanford (S.C.), and the City of Hope Comprehensive Cancer Center, Duarte (A.H.) - both in California; Dana-Farber Partners CancerCare (J.R.B., R.M.S.) and the Massachusetts General Hospital Cancer Center (J.S.A.) - both in Boston; Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN (S.N.); University of Chicago Comprehensive Cancer Center (R.A.L.) and Loyola University Chicago (S.E.S.) - both in Chicago; the University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada (C.O.); and the Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (R.F.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1812836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325637PMC
December 2018

A dynamic N-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors.

Cell Res 2018 11 8;28(11):1062-1076. Epub 2018 Oct 8.

The Hormel Institute, University of Minnesota, Austin, MN, 55912, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41422-018-0097-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218444PMC
November 2018

No free rides: management of toxicities of novel immunotherapies in ALL, including financial.

Blood Adv 2018 11;2(22):3393-3403

Division of Hematology and Bone Marrow Transplant, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018020198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258912PMC
November 2018

No free rides: management of toxicities of novel immunotherapies in ALL, including financial.

Hematology Am Soc Hematol Educ Program 2018 11;2018(1):25-34

Division of Hematology and Bone Marrow Transplant, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2018.1.25DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246022PMC
November 2018

Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia.

Blood Lymphat Cancer 2018 25;8:47-61. Epub 2018 Sep 25.

Division of Hematology, Mayo Clinic, Rochester, MN, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BLCTT.S170351DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467350PMC
September 2018

Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia.

Curr Hematol Malig Rep 2018 08;13(4):265-274

Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-018-0455-9DOI Listing
August 2018

HDL-AuNPs-BMS Nanoparticle Conjugates as Molecularly Targeted Therapy for Leukemia.

ACS Appl Mater Interfaces 2018 May 18;10(17):14454-14462. Epub 2018 Apr 18.

The Hormel Institute , University of Minnesota , Austin , Minnesota 55912 , United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsami.8b01696DOI Listing
May 2018

Continuing challenges and current issues in acute lymphoblastic leukemia.

Leuk Lymphoma 2018 03 11;59(3):526-541. Epub 2017 Jun 11.

a Division of Hematology and Bone Marrow Transplant , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1335397DOI Listing
March 2018

Hematopoietic stem cell transplant in adults with acute lymphoblastic leukemia: the present state.

Expert Rev Hematol 2018 03 7;11(3):195-207. Epub 2018 Feb 7.

a Division of Hematology and Bone Marrow Transplant , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2018.1433030DOI Listing
March 2018

Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia.

Leuk Lymphoma 2018 01 8;59(1):229-232. Epub 2017 Jun 8.

a Department of Cardiovascular Medicine , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1323268DOI Listing
January 2018

Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single-Institution Retrospective Case Series.

Mayo Clin Proc 2017 11 1;92(11):1617-1624. Epub 2017 Nov 1.

Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2017.08.016DOI Listing
November 2017

Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia.

Clin Cancer Res 2017 Oct 18;23(20):6254-6266. Epub 2017 Jul 18.

The Hormel Institute, University of Minnesota, Austin, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-0235DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641248PMC
October 2017

Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2017 Sep 8;23(9):1478-1484. Epub 2017 May 8.

Division of Hematology, Mayo Clinic, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.05.001DOI Listing
September 2017

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117.

J Clin Oncol 2017 Aug 9;35(24):2745-2753. Epub 2017 May 9.

Mikkael A. Sekeres and Aziz Nazha, Cleveland Clinic, Cleveland; Clara D. Bloomfield, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Megan Othus and Anna Moseley, SWOG Statistical Center; Min Fang and Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan F. List, H. Lee Moffitt Cancer Center, Tampa, FL; Olatoyosi Odenike, University of Chicago, Chicago; Mario R. Velasco, Heartland NCORP/Cancer Care Specialists of Central Illinois, Decatur, IL; Richard M. Stone, Dana Farber Cancer Institute; Eyal C. Attar, Massachusetts General Hospital, Boston, MA; Steven D. Gore, Yale University, New Haven, CT; Mark R. Litzow, Mayo Clinic, Rochester, MN; Rena Buckstein, Sunnybrook Health Sciences Centre, Toronto; Elina K. Cook, Alyssa H. Cull, and Michael J. Rauh, Queen's University, Kingston, Ontario, Canada; Diane Roulston, University of Michigan, Ann Arbor, MI; Yanming Zhang, Memorial Sloan-Kettering Cancer Center, New York, NY; Rakesh Gaur, Kansas City National Cancer Institute Community Oncology Research Program, Prairie Village, KS; Ehab Atallah, Medical College of Wisconsin, Milwaukee, WI; and Harry P. Erba, University of Alabama, Birmingham, AL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.2510DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562170PMC
August 2017

Treatment of Young Adults with Acute Lymphoblastic Leukemia.

Curr Hematol Malig Rep 2017 06;12(3):187-196

Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-017-0377-yDOI Listing
June 2017

What Is the Best Daunorubicin Dose and Schedule for Acute Myeloid Leukemia Induction?

Curr Treat Options Oncol 2017 01;18(1)

Division of Hematology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-017-0446-4DOI Listing
January 2017